Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

1. McLarty T, Giglione A, Miller J L, Lewis T V, Johnson P N. Systematic Review of Pharmacologic Treatments for Hypochloremic Metabolic Alkalosis in Critically Ill Children. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2026; 31 : 4-17

2. Foote D, Le M, Johnson P N, Miller J L, Behere S, Stephens K S. Ivabradine Use for Arrhythmias in Children. The Annals of pharmacotherapy. 2025

3. Whittington L M, Johnson P N, Fliehman D, Hayes K, Taylor S, Van Devender E A, Chan R. Supporting resident well-being: Considerations for residency program directors and pharmacy enterprise leadership. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2025; 82 : e915-e920

4. Moore B, Johnson P N, Miller J L. A Structured Approach to Identifying and Addressing Drug Therapy Problems in Neonatal and Pediatric Critically Ill Patients: IN-DEPTH. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 696-704

5. McLarty T, Miller J L, Lewis T V, Neely S, Johnson P N. Evaluation of Research and Scholarship Activities with a Pediatric Curricular Track in a Doctor of Pharmacy Program. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 607-616

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Ellie Malehorn). Date: 2025.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Avery Parman). Date: 2024.


3. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


4. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


5. Society of Critical Care Medicine Presidential Citation. Date: 2022.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results